Q4 2025 · 13F-HR
Brummer Multi-Strategy ABholdings as filed
Filed 2026-02-04 · accession 0002003159-26-000002
$16.5M
Reported value
11
Positions
2025-12-31
Period end
The Brief · Brummer Multi-Strategy AB · Q4 2025
AI · grounded in 13F
Brummer Multi-Strategy AB established a new position in CI valued at $3.25M. The fund also added new stakes in ARVN for $1.97M and ABVX for $1.94M. To fund these moves, the manager closed positions in PTCT and CIGI, reducing exposure by $1.17M and $691K respectively.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 65158N102 | NMRK | NEWMARK GROUP INC | $3.5M | 21.0% | 200,493 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $3.3M | 19.7% | 11,818 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $2.0M | 11.9% | 166,342 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $1.9M | 11.7% | 14,375 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $1.8M | 11.1% | 8,183 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $1.5M | 8.99% | 457,707 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $1.0M | 6.07% | 5,176 | Common | SOLE |
| N0731H103 | ATAI | ATAI BECKLEY NV | $960,802 | 5.81% | 234,915 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $404,708 | 2.45% | 8,741 | Common | SOLE |
| 49876K103 | GRML | KLOTHO NEUROSCIENCES INC | $175,353 | 1.06% | 606,757 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $25,423 | 0.15% | 4,708 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.